![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25273-25280, September 3, 1999
From the Institute for Biomedical Aging Research, Austrian Academy of Sciences, A-6020 Innsbruck, Austria
| |
ABSTRACT |
|---|
|
|
|---|
Recently, we demonstrated that mechanical stress
results in rapid phosphorylation or activation of platelet-derived
growth factor receptors in vascular smooth muscle cells (VSMCs)
followed by activation of mitogen-activated protein kinases (MAPKs) and AP-1 transcription factors (Hu, Y., Bock, G., Wick, G., and Xu, Q. (1998) FASEB J. 12, 1135-1142). Herein, we provide
evidence that VSMC responses to mechanical stress also include
induction of MAPK phosphatase-1 (MKP-1), which may serve as a negative
regulator of MAPK signaling pathways. When rat VSMCs cultivated on a
flexible membrane were subjected to cyclic strain stress (60 cycles/min, 5-30% elongation), induction of MKP-1 proteins and
mRNA was observed in time- and strength-dependent
manners. Concomitantly, mechanical forces evoked rapid and transient
activation of all three members of MAPKs, i.e.
extracellular signal-regulated kinases (ERKs), c-Jun
NH2-terminal protein kinases (JNKs), or stress-activated protein kinases (SAPKs), and p38 MAPKs. Suramin, a growth factor receptor antagonist, completely abolished ERK activation, significantly blocked MKP-1 expression, but not JNK/SAPK and p38 MAPK activation, in
response to mechanical stress. Interestingly, VSMC lines stably expressing dominant negative Ras (Ras N17) or Rac (Rac N17) exhibited a
marked decrease in MKP-1 expression; the inhibition of ERK kinases (MEK1/2) by PD 98059 or of p38 MAPKs by SB 202190 resulted in a
down-regulation of MKP-1 induction. Furthermore, overexpressing MKP-1
in VSMCs led to the dephosphorylation and inactivation of ERKs,
JNKs/SAPKs, and p38 MAPKs and inhibition of DNA synthesis. Taken
together, our findings demonstrate that mechanical stress induces MKP-1
expression regulated by two signal pathways, including growth factor
receptor-Ras-ERK and Rac-JNK/SAPK or p38 MAPK, and that MKP-1 inhibits
VSMC proliferation via MAPK inactivation. These results suggest that
MKP-1 plays a crucial role in mechanical stress-stimulated signaling
leading to VSMC growth and differentiation.
Intracellular signaling stimulated by growth factors, cytokines,
osmotic shock, and stress involves the initiation of one or more
phosphorylation cascades leading to the rapid and reversible activation
of mitogen-activated protein kinases
(MAPKs),1 a family of
ubiquitous and well characterized serine/threonine kinases thought to
play a critical role in regulating cellular events required for cell
growth, differentiation, and apoptosis (1-3). Three major subfamilies
of MAPKs have been identified, including the extracellular
signal-regulated kinases (ERKs), c-Jun NH2-terminal protein
kinases (JNKs) or stress-activated protein kinases (SAPKs), and p38
MAPKs (1-3). They are strongly activated in the arterial wall in
response to angioplasty (4-7), hypertension (8), and
hypercholesterolemia,2 which
are risk factors for vascular diseases.
MAPK phosphatase-1 (MKP-1) has dual catalytic activity toward
phosphotyrosine- and phosphothreonine-containing proteins and is known
to inactivate ERKs and possibly JNKs/SAPKs (9-12), which play an
important role in the regulation of mitogenesis. MKP-1, regulated at
the transcriptional level, is induced in vascular smooth muscle cells
(VSMCs) by growth factors (13), oxidative stress (14), arachidonic acid
(15), and 12-O-tetradecanoylphorbol-13-acetate (16).
Although MKP-1 has been implicated in a feedback loop that inactivates
MAPKs after stimulation by mitogens and during the cellular response to
stress (10, 12, 17, 18), signal pathways leading to MKP-1 gene
expression are not fully elucidated.
In vivo, vessel walls are exposed to three main hemodynamic
forces: shear stress, the dragging frictional force created by blood
flow; transmural pressure, created by the hydrostatic forces of blood
within the blood vessel; and mechanical stretch or tension, a cyclic
strain stress created by blood pressure (19, 20). VSMCs are one of the
major constituents of blood vessel wall responsible for the maintenance
of vascular tone (21). Factors ranging from physical exertion to
psychological stress lead to a transient rise in blood pressure (22,
23), and if the factors are persistent and chronic, the arteriole walls
gradually thicken, resulting in hypertension (22-25). In humans,
atherosclerotic lesions occur preferentially at bifurcations and
curvatures (26), where hemodynamic force is disturbed (27). There is
growing evidence that mechanical force initiates intracellular
signaling and regulates the synthesis and/or secretion of numerous
factors, including NO (28), prostacyclin (29), endothelin-1 (30),
platelet-derived growth factor, fibroblast growth factor (31, 32), and
angiotensin II (33, 34), which are crucial factors in maintaining the
homeostasis of the vessel wall. Thus, mechanical stress plays an
important role in the development of hypertension and atherosclerosis
(35).
Xu et al. (36) have previously shown that acute hypertension
induces a rapid and transient expression of MKP-1 mRNA followed by
elevated MKP-1 protein in rat aorta. The MKP-1 induction is blocked by
prevention of elevation in blood pressure, i.e.
administration of the vasodilator agent sodium nitroprusside. However,
it is not known whether MKP-1 production is initiated by hemodynamic force per se or by hormones, cytokines in vivo.
In the present study, we evaluated potential effects of mechanical
stress on MKP-1 induction in VSMCs cultivated on a flexible membrane
and subjected to cyclic strain stress. We demonstrated that mechanical stress causes rapid MKP-1 expression in VSMCs, which appears to be
mediated by Ras- and Rac-MAPK pathways, respectively.
Materials--
A rat MKP-1 cDNA was isolated from rat lung
cDNA library by Liu et al. (11). Polyclonal antibodies
against MKP-1, ERK1/2, JNK/SAPK, and mouse monoclonal antibodies
against phosphorylated-ERK1/2, -JNK1/2, and -p38 MAPK and against
Ha-Ras were obtained from Santa Cruz Biochem., Santa Cruz, CA. Suramin
and G418 were obtained from Sigma. PD 98059 and SB 202190 were
purchased from Calbiochem-Novaniochem. Plasmids expressing dominant
negative Ras (Ras N17) and dominant negative Rac1 (Rac1 N17) and
myc-tagged antibody were provided by G. Baier (Institute for Medical
Biology and Human Genetics, University of Innsbruck, Austria).
SuperFect reagent for transfection was purchased from Qiagen (Valencia, CA).
Cell Culture--
VSMCs were isolated by enzymatic digestion of
rat aortas using a modification of the procedure of Ross and Kariya
(37), as described previously (38), and cultured in Dulbecco's
modified Eagle's medium (Life Technologies, Inc.) supplemented with
20% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 µg/ml). Cells were incubated at 37 °C in a humidified atmosphere of 5% CO2. The medium was changed every 3 days, and cells
were passaged by treatment with 0.2% trypsin, 0.02% EDTA solution. Experiments were conducted on VSMCs that had just achieved confluence.
Stable Transfection--
Rat VSMCs were transfected with Ras
N17, Rac N17, and MKP-1 plasmids, respectively, by using SuperFect Kit
according to the manufacture's instructions. After transfection, the
cells were cultured for 24 h, divided 1 to 4, and placed in
culture medium supplemented with 20% fetal calf serum and 150 µg/ml
G418 to select those carrying a neomycin-resistant plasmid. When 80%
cell death in a parallel group of normal VSMCs was observed, the medium
containing 150 µg/ml G418 was changed into medium containing 50 µg/ml G418 to maintain selection. After 4-8 weeks, individual cell
colonies were transferred for clone expansion and maintained in culture medium supplemented with 20% fetal calf serum and 50 µg/ml G418. Ras
N17-, Rac N17-, and MKP-1-transfected VSMCs were identified by Western
blotting analysis with antibodies to Ha-Ras, myc-tagged, and MKP-1 proteins.
Cyclic Strain Stress--
VSMCs were plated on silicone
elastomer-bottomed culture plates (Flexcell, Meckeesport, PA). Cells
achieving 90% confluence were serum-starved for 3 days and subjected
to mechanical stress with the Cyclic Stress Unit, a modification of the
unit initially described by Banes et al. (39) consisting of
a controlled vacuum unit and a base plate to hold the culture plates
(FX3000 AFC-CTL, Flexcell). A vacuum (15 to 20 kilopascals) was
repeatedly applied to the elastomer-bottomed plates via the base plate,
which was placed in a humidified incubator with 5% CO2 at
37 °C. Cyclic deformation (60 cycles/min) and 5 to 30% elongation
of elastomer-bottomed plates were used (40).
Cell Pretreatment--
VSMCs, growing in silicone
elastomer-bottomed culture plates to 90% confluence, were
serum-starved for 3 days, and suramin, PD 98059, or SB 202190 was added
and incubated for 1 h before application of cyclic strain stress.
Protein Extraction and Western Blot Analysis--
After strain
stress, VSMCs were washed twice with cold (4 °C) phosphate-buffered
saline (pH 7.4) and harvested on ice in buffer A containing 20 mM Hepes (pH 7.4), 2 mM EDTA, 50 mM
Membrane protein preparation for Ras and Rac analysis was similar to
that described by Pomerantz et al. (41). Briefly, VSMCs were
washed with cold phosphate-buffered saline (4 °C), scraped in
phosphate-buffered saline, pelleted, and resuspended in 500 µl of
homogenizing buffer (25 mM Hepes, 1.0 mM EDTA,
1 µg/ml leupeptin, 1 µg/ml pepstatin A, and 100 µM
phenylmethylsulfonyl fluoride). Cells were sonicated for 10 s and
centrifuged at 2,000 rpm for 10 min to remove debris. The supernatant
was centrifuged at 55,000 × g for 1 h at 4 °C.
The cytosolic supernatant was removed, the membrane pellet was
resuspended in 50 µl of homogenizing buffer and sonicated for 10 s, and protein concentration was measured. For total protein extract,
cells were washed with cold phosphate-buffered saline (4 °C),
pelleted, resuspended in 100 µl of buffer A, sonicated for 10 s,
and centrifuged at 2,000 rpm for 10 min before supernatant harvest. For
Ras and Rac protein analysis, 30-100 µg of membrane protein was used
in reduced conditions (2.5% SDS, 250 µM dithiothreitol for 5 min at 90 °C). The procedure used for Western blot analysis was similar to that described previously (42). In short, 30-100 µg
of proteins were separated by electrophoresis through a 10% or 12%
SDS-polyacrylamide gel and transferred onto nitrocellulose membranes.
The blots were probed with antibodies against MKP-1, Ha-Ras, myc-tagged
Rac1, phosphorylated-ERK1/2, -JNK1/2, or -p38 MAPK, and specific
antibody-antigen complexes were detected using the ECL Western blot
Detection Kit (Amersham Pharmacia Biotech). Graphs of blots were
obtained in the linear range of detection and were quantified for the
level of specific induction by scanning laser densitometry (Power-Look
II, UMAX Data System Inc., Hsinchu, Taiwan) of graphs.
RNA Isolation and Northern Blot--
Total RNA was isolated as
described elsewhere (36). RNA (10 µg/lane) was denatured with
formaldehyde (Merck), electrophoresed in a 1% agarose gel, transferred
onto nylon membrane (Zeta Probe, Bio-Rad), and UV-cross-linked in a UV
Stratalinker (Stratagene Inc., La Jolla, CA). Hybridizations were
performed using a fluorescein-labeled (Amersham Pharmacia Biotech)
cDNA probe for MKP-1, as described previously (36). The membranes
were then washed, detected with antifluorescein alkaline phosphatase
conjugate (1:5,000) (Amersham Pharmacia Biotech), and exposed to ECL
films. Graphs of blots were obtained in the linear range of detection.
Accuracy of loading and transfer as well as RNA integrity was confirmed
by quantitative analysis of the 28 S and 18 S RNA.
Kinase Assays--
For kinase assays, 0.5 ml of supernatant
containing 0.5 mg of proteins were incubated with 10 µl of antibodies
against mammalian ERK2, JNK/SAPK, or p38 MAPKs for 2 h at 4 °C
with rotation. Subsequently, 40 µl of protein G-agarose suspension
(Santa Cruz Biotech. Inc.) was added and rotation was continued for
1 h at 4 °C. Immunocomplexes were precipitated by centrifuge
and washed twice with buffers A, B (500 mM LiCl, 100 mM Tris, 1 mM dithiothreitol, 0.1% Triton X-100, pH 7.6), and C (20 mM Mops, 2 mM EGTA,
10 mM MgCl2, 1 mM dithiothreitol,
0.1% Triton X-100, pH 7.2), respectively.
ERK2 or p38 activities in the immunocomplexes were measured as
described previously (43, 44). Briefly, immunocomplexes were incubated
with myelin basic protein (6 µg; Upstate Biotechnology, Inc., Lake
Placid, NY) and [
The assay for JNK/SAPK activity was performed as described above using
GST-c-Jun as a substrate (the plasmid was provided by Dr. J. Woodgett)
produced in Escherichia coli and isolated using glutathione
Sepharose 4B RediPack columns (Amersham Pharmacia Biotech) per
manufacturer's protocol. Proteins in the kinase reaction were resolved
by SDS- polyacrylamide gel electrophoresis (12% gel) and subjected to
autoradiography (3, 43, 44).
[3H]Thymidine Incorporation--
Transfected VSMCs
cultured in the flexible plates in medium containing 20% fetal calf
serum at 37 °C for 24 h were serum-starved for 4 days. VSMCs
were stressed by elongation of 15% for 30 min (60 cycles/min) and
incubated at 37 °C for 24 h. [3H]Thymidine was
added 4 h before cell harvest. Radiation activities were measured.
Statistical Analysis--
Analysis of variance was performed
when more than two groups were compared. An unpaired Student's
t test was used to assess differences between two groups. A
p value less than 0.05 was considered significant.
Cyclic Strain Stress Induced MKP-1 Expression--
To explore the
possibility that the expression of MKP-1 is altered after mechanical
stress, MKP-1 mRNA in stressed VSMCs were determined by Northern
blot analysis. As shown in Fig.
1A, strain stress treatment
(60 cycles/min, 15% elongation) resulted in significant increases in
MKP-1 mRNA. Kinetic analysis indicates that this response occurred
as early as 8 min with maximum induction achieved 30 min after
treatment and declining thereafter (Fig. 1A). Fig. 1B showed 18 S and 28 S RNA from the corresponding blot,
indicating a similar amount of RNA loaded. Likewise, growth-arrested
VSMCs were exposed to cyclic strain stress for various times, and
protein extracts from control and treated cells were analyzed for MKP-1 induction. As shown in Fig. 1C, cells treated with
mechanical stress resulted in a time-dependent induction of
MKP-1 proteins that was evident at 8 min, peaked at 30 min, and
returned to basal line by 4 h. Fig. 1D summarizes data
of MKP-1 protein induction as determined by quantification of optical
densities from autoradiograms of three experiments. A significant
increase in MKP-1 proteins of VSMCs was observed between 30 min and
3 h.
To further establish the relationship between mechanical strain stress
and MKP-1 expression, a tensile strength response analysis of
mechanical stress-induced MKP-1 mRNA accumulation was performed. As
shown in Fig. 2A, VSMCs were
stretched for elongation of 5, 10, 15, 20, 25, and 30% of original
size, respectively, and the increase of MKP-1 mRNA amounts
corresponded with the increased magnitudes of stretch stress of
5-20%. Fig. 2B shows the amount of 18 S and 28 S RNA from
the corresponding blot. Similar results were observed at the level of
MKP-1 proteins (Fig. 2C). Fig. 2D shows
statistical data from three experiments. A significant induction was
found in stressed VSMCs elongated between 10 and 30%. Our results
provided the first evidence that MKP-1 is induced by mechanical stress
in VSMCs.
There is evidence that mechanical force rapidly activates ERK and
JNK/SAPK in VSMCs (45, 46), but no data exists as to whether p38 MAPK
is also activated in response to cyclic strain stress. Phosphorylation
of p38 MAPK, ERK1/2, and JNK1/2 was determined by Western blot analysis
using anti-phosphorylated-p38 MAPK, -ERK1/2, and -JNK1/2 antibodies,
respectively. Fig. 3A shows
phosphorylation of p38 MAPK in VSMCs treated with cyclic strain stress
for various times. The highest level of p38 phosphorylation was
obtained between 8 and 30 min and declined thereafter. Similarly, ERK
1/2 phosphorylation was evident, but ERK proteins did not alter in
response to strain stress (Fig. 3, B and C). ERK
activity was measured for immunoprecipitated ERK2 to phosphorylate
myelin basic protein, indicating that mechanical strain stress induced
marked ERK activation (Fig. 3D). Strain stress also resulted
in a rapid activation of JNK/SAPK (Fig. 3, E and
F) in VSMCs. The activities of three MAPKs declined between 30 and 120 min in response to mechanical stress (Fig. 3), whereas higher levels of MKP-1 proteins persisted (Fig. 1C),
suggesting a role of MKP-1 on inactivation of MAPKs.
Suramin Partially Blocked MKP-1 Expression--
We recently
demonstrated that mechanical stress directly stimulates
platelet-derived growth factor receptor phosphorylation or activation
and that suramin, a broad spectrum receptor antagonist, blocked such
activation (40). It was not known if growth factor receptors were also
responsible for MKP-1 induction during mechanical stress. Suramin
treatment markedly blocked MKP-1 expression (Fig. 4A), suggesting that the
initial signal in mechanical stressed-VSMCs is, at least in part,
generated on the plasma membrane via growth factor receptor activation.
As expected, suramin completely blocked mechanical stress-stimulated
phosphorylation of ERK (Fig. 4B) but not JNK/SAPK (Fig.
4C). Surprisingly, it apparently enhanced the activation of
p38 MAPK (Fig. 4D). These results suggest that suramin-blocked MKP-1 expression may be due to inhibition of the growth
factor receptor-ERK pathway, independent of the JNK/SAPK and P38 MAPK
pathways.
Involvement of Ras/Rac in MKP-1 Expression--
A large number of
extracellular signals stimulates Ras activation, resulting in
Ras-dependent MAPK activation. Recent data reported by Gudi
et al. (47) indicate that Ras protein was activated in
response to shear stress in endothelial cells. It would be interesting
to determine whether Ras also mediates MKP-1 expression in stressed
VSMCs. VSMCs were stably transfected with plasmid-expressing dominant
negative Ras (Ras N17) or a vector plasmid as control. Since plasmids
contain the selective marker gene neo, multiple G418-resistant colonies were selected and tested for expression of Ras
protein by Western blotting analysis with anti-Ha-Ras antibody. As
shown in Fig. 5A, Ras protein
was at a lower level in vector-transfected controls and much higher in
Ras-transfected cells. Ras N17 expression reduced ERK activation (Fig.
5B) and significantly blocked MKP-1 induction (Fig. 5,
C and D), indicating
Ras-ERK-dependent MKP-1 induction. Interestingly, stronger
stress (25% elongation)-induced MKP-1 expression can only be partially
blocked by Ras N17, suggesting that other signal pathways may be also
involved.
Rac is a member of the Ras superfamily of small GTP-binding proteins.
Increasing evidence indicates that members of Rac regulate a diverse
array of cellular events, including the control of cell growth,
cytoskeletal reorganization and the activation of protein kinases, and
cardiac myocyte hypertrophy (48). To explore the role of Rac in MKP-1
expression in stress-stimulated VSMCs, we established VSMC lines stably
expressing Rac1, encoding a myc-tagged form of a dominant negative Rac1
(Rac1 N17) that expressed a high level of this gene product (Fig.
6A). Surprisingly,
overexpression of Rac1 N17 markedly inhibited ERK1/2 phosphorylation
(Fig. 6B), indicating Rac-dependent ERK
activation in response to mechanical stress. We next assessed the
effects on MKP-1 expression in the Rac1 N17 cell lines treated with
mechanical stress. As seen in Fig. 6, C and D,
MKP-1 expression in Rac1 N17 cell lines was much lower than in
vector-transfected cell lines. The results suggest that Rac plays an
important role in the signal transduction leading to MKP-1 expression
in VSMCs.
ERK- and p38-dependent MKP-1 Induction--
As shown
in Figs. 1 to 3, ERK, JNK, and p38 MAPK activation by mechanical stress
proceeded to MKP-1 expression. To investigate whether these kinases are
involved in strain stress-stimulated MKP-1 expression, ERK, JNK, and
p38 MAPK phosphorylation and MKP-1 expression were simultaneously
determined in stressed VSMCs treated with PD 98059, a specific MAPK
kinase (MEK1/2) inhibitor. Mechanical stress-induced ERK1/2
phosphorylation was completely abolished by PD 98059 pretreatment (Fig.
7A) but not JNKs/SAPKs (Fig.
7B) and p38 MAPKs (Fig. 7C). MKP-1 induction was
evidently inhibited (Fig. 7D). These results support the
notion that mechanical stress-induced MKP-1 expression is partially
dependent on ERK activation. Furthermore, p38 MAPK activity was
abrogated by SB 202190, a specific inhibitor for p38 MAPKs (Fig.
8A). It was unexpected that
mechanical stress-induced MKP-1 expression was also inhibited, at least
in part (Fig. 8B). These observations implicate the
involvement of p38 MAPKs in the MKP-1 induction.
MKP-1 Inhibited MAPK Activation and VSMC Proliferation--
To
study the effects of MKP-1 on MAPK activation and on VSMC
proliferation, we established VSMC lines overexpressing MKP-1 and
determined ERK, JNK/SAPK, and p38 MAPK phosphorylation and DNA
synthesis in response to mechanical stress. Transfected clones stably
expressing MKP-1 were identified by Western blot analysis. Although our
antibody could not differentiate endogenous rat MKP-1 from
overexpressed rMKP-1 proteins, the cells under low growth conditions
(2% calf serum or 5% stretch elongation) minimized endogenous MKP-1
to an undetectable level, as seen in the Western blot (Fig.
9A). Cells transfected with
MKP-1-expressing plasmids showed a high level of MKP-1 (Fig.
9A). Compared with vector-transfected cells, a 50-80%
reduction in ERK, JNK/SAPK, and p38 MAPK phosphorylation was observed
in MKP-1-expressing VSMCs when stimulated with mechanical stress (Fig.
9, B-D). To determine the effects of MKP-1 on DNA synthesis
induced by mechanical stress, rMKP-1 or vector-transfected cell lines
were stimulated by mechanical stress for 30 min. As shown in Fig.
9E, [3H]thymidine incorporation in
rMKP-1-expressing VSMCs was significantly lower than vector-transfected
cells. These results suggest that MKP-1 inhibits VSMC growth via
inactivation or dephosphorylation of three MAPKs.
Recent evidence indicates that mechanical stress is an important
extracellular stimulus and regulates gene expression, protein synthesis, and growth and differentiation of cardiovascular cells (28-34, 45-55). The present study demonstrates for the first time that mechanical stress causes MKP-1 expression, which is crucial in
regulation of MAPK activities in VSMCs. Mechanical stress also induces
activation of ERK1/2, JNKs/SAPKs, and p38 MAPKs. This process involves
small molecular GTP-binding proteins, Ras and Rac. These results have
several implications. First, understanding that strain stress induces
MKP-1 expression may strengthen the notion that mechanical stress plays
an important role in regulating VSMC growth. Although strain stress
stimulates ERK, JNK/SAPK, and p38 MAPK activation, which appears to be
a component common to signaling pathways initiated by a wide range of
growth-stimulating factors, including mitogens and hormones (1-3,
56-61), MKP-1 serves as a negative regulator, controlling cell growth
via inactivation of three MAPKs. Second, mechanical stress plays a
crucial role in the regulation of VSMC tone caused by autocrine and
paracrine vasoconstrictors (28-30, 51), such as angiotensin II and
endothelin-1, which result in MKP-1 expression. In this process, MKP-1
might be involved in inactivation of numerous kinases that influence cell tone. Finally, stress-induced MKP-1 expression is not only mediated by Ras but also by Rac proteins, suggesting a complicated network of stress-induced signaling in VSMCs. Thus, our findings could
significantly advance our understanding of the role of MKP-1 in VSMC
proliferation, which is a key event in the pathogenesis of
hypertension-related arteriosclerosis, angioplasty-induced restenosis,
and vein graft arteriosclerosis.
How do the VSMCs sense and transduce the signals in response to
mechanical stress, leading to MKP-1 expression? One possibility is that
growth factor receptor activation is partially responsible for
mechanical stress-induced MKP-1 expression. This concept is supported
by our previous observation that mechanical stress could induce rapid
phosphorylation of platelet-derived growth factor receptors in VSMCs
(40). Suramin, a growth factor receptor antagonist, inhibited
phosphorylation of platelet-derived growth factor receptor (40) and
could also significantly inhibit stress-induced MKP-1 expression (Fig.
4). As we previously hypothesized (40), mechanical stress elongates and
changes cellular morphology, leading to receptor conformation,
resulting in exposure of the kinase domain and subsequent autophosphorylation. Thus, the mechanism of mechanical stress-induced MKP-1 expression is similar to growth factor-stimulated MKP-1 induction. Since suramin could not completely block MKP-1 expression, another possible primary mechanosensor candidate may be G proteins. Recent reports by Gudi et al. (47) indicate that G proteins may act as primary mechanosensors in shear-stressed endothelial cells.
Treatment of endothelial cells with antisense G
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glycerophosphate, 1 mM dithiothreitol, 1 mM
Na3VO4, 1% Triton, 10% glycerol, 1 µg/ml leupeptin, 1 µg/ml aprotinin, 100 µM
phenylmethylsulfonyl fluoride. The suspension was incubated on ice for
20 min with vortexing every 5 min. Cellular debris were then pelleted
by centrifugation for 30 min at 13,000 rpm (Eppendorf centrifuge,
Osterode, Germany) at 4 °C, supernatants were collected, and protein
concentration measured by the Bio-Rad assay.
-32P]ATP (5 µCi) for 20 min. To
stop the reaction, 15 µl of 4× Laemmli buffer was added, and the
mixture was boiled for 5 min. Proteins in the kinase reaction were
resolved by SDS-polyacrylamide gel electrophoresis (15% gel) and
subjected to autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 1.
Time course of MKP-1 expression in VSMCs
exposed to mechanical stress. Serum-starved VSMCs were treated
with cyclic strain stress (60 cycles/min, 15% elongation) for the
indicated times and harvested. Panel A, Northern blot
analysis. Total RNA was extracted from VSMCs, and 10 µg of total
RNA/lane were electrophoresed on 1% agarose and transferred
to membrane. The integrity and quantity of RNA were verified by
analysis of 18 S and 28 S RNA (panel B). Northern blots were
hybridized with MKP-1 cDNA probes. Data are representative of two
independent experiments. Panel C, Western blot analysis.
After treatment, cells were lysed in the buffer A, and protein extracts
were separated on 10% SDS-polyacrylamide gel, transferred to
membranes, and probed using an antibody to MKP-1 protein. Panel
D shows statistical data of MKP-1 protein induction from VSMCs
treated with mechanical stress. *, significant difference from control,
p < 0.05. S, fetal calf serum treatment as
a positive control.

View larger version (43K):
[in a new window]
Fig. 2.
Effects of mechanical stress strength on
MKP-1 induction. VSMCs were serum-starved for 3 days and treated
with strain stress (60 cycles/min, 5-30% elongation) for 30 min.
Northern blots (panels A and B) and Western blot
(panel C) were performed as described in the legend to Fig.
1 and under "Experimental Procedures." Panel D
summarizes the results of Western blots of three independent
experiments. *, significant difference from control, p < 0.05. S, fetal calf serum treatment as a positive
control.

View larger version (40K):
[in a new window]
Fig. 3.
Mechanical stress-induced ERK and JNK/SAPK
and p38 MAPK activation. Serum-starved VSMCs were treated with
strain stress (60 cycles/min, 15% elongation) for the indicated times
and harvested for protein extracts. The results of Western blot
analysis were shown for phosphorylated (P) p38 (panel
A), ERK1/2 (panel B), and JNK1/2 (panel E).
For the kinase assay, ERK2 and JNK1 proteins were immunoprecipitated
from the protein extracts, and their kinase activities were measured
based on phosphorylation of myelin basic protein (MBP)
substrate (panel D) and GST-c-Jun fusion protein substrate
(panel F). Panel C shows the total ERK1/2
proteins labeled with anti-pan-ERK1/2 antibodies for each sample
tested. Data represent similar results from three independent
experiments. S, fetal calf serum treatment as positive
controls.

View larger version (36K):
[in a new window]
Fig. 4.
Effects of suramin on MKP-1 expression.
Quiescent VSMCs were pretreated with suramin (0.3 mM) for
30 min. Cells were treated with cyclic strain stress for 8 or 30 min,
respectively, and harvested for protein extracts. The results of
Western blot analysis are shown for MKP-1 (panel A),
phosphorylated (P) ERK1/2 (panel B), JNK1/2
(panel C), p38 MAPK (panel D). The experimental
procedures are similar to those described in the legend to Fig. 1. Data
are representative of similar results of three independent experiments.
S, fetal calf serum treatment as positive controls.

View larger version (43K):
[in a new window]
Fig. 5.
Involvement of Ras in MKP-1 expression.
Rat VSMCs were stably transfected with constructs expressing dominant
negative Ras (pEF-Ras N17) or vector (pEF-neo) using the SuperFect
reagent in a ratio of 1 to 2 (w/w). The transfected cells were cultured
overnight, divided 1 to 4, and placed in culture medium supplemented
with 150 µg/ml G418. VSMC lines expressing Ras N17 were identified
with anti-Ha-Ras (H-Ras) antibody, as determined by Western
blotting (panel A). VSMC lines were serum-starved for 3 days
and treated with mechanical stress for the indicated times (60 cycles/min, 15% elongation) (panels B and C) or
the indicated elongations for 1 h (panel D). Western
blot analysis was performed using anti-phosphorylated (P)
ERK1/2 (B) or anti-MKP-1 (C and D)
antibodies. Data represent similar results from three independent
experiments.

View larger version (40K):
[in a new window]
Fig. 6.
Involvement of Rac in MKP-1 expression.
The procedures for establishing stably expressing dominant negative
Rac1 (pEF-Rac1 N17) cell lines are similar to those described in the
legend to Fig. 5 and under "Experimental Procedures." Panel
A shows the results of Western blot analysis using anti-myc-tag
antibody. VSMC cell lines were serum-starved for 3 days and treated
with mechanical stress for the indicated times (15% elongation)
(Panel C) and the indicated elongations for 1 h
(panel D). Western blot analysis was performed using
anti-phosphorylated (P) ERK1/2 (B) or
anti-MKP-1 (C and D) antibodies. Data
represent similar results from three independent experiments.

View larger version (38K):
[in a new window]
Fig. 7.
ERK-dependent MKP-1
induction. Quiescent VSMCs were pretreated with PD 98059 (50 µM) for 1 h. Cells were stressed for 8 or 30 min,
respectively, and harvested for protein extracts. The results of
Western blot analysis were shown for phosphorylated (P)
ERK1/2 (panel A), JNK1/2 (panel B), p38 MAPK
(panel C), and MKP-1 (panel D). The procedures
are similar to those described in the legend to Fig. 3. Data represent
similar results from three independent experiments. S, fetal
calf serum treatment as positive controls.

View larger version (42K):
[in a new window]
Fig. 8.
p38 MAPK-dependent MKP-1
induction. Quiescent VSMCs were pretreated with SB 202190 (5 µM) for 1 h. Cells were stressed for 8 or 30 min,
respectively, and harvested for protein extracts. p38 MAPK activities
were measured based on phosphorylation of myelin basic protein
(MBP; panel A). The results of Western blot
analysis for MKP-1 were shown in panel B. Data represent
similar results from two independent experiments. S, fetal
calf serum treatment as a positive control.

View larger version (27K):
[in a new window]
Fig. 9.
MKP-1 inhibited MAPK activation and VSMC
proliferation. The experimental procedures for establishing rMKP-1
(pSG5-rMKP-1) or vector (pSG5-neo)-transfected cell lines are similar
to those described in the legend to Fig. 5 and under "Experimental
Procedures." Panel A shows results of Western blot
analysis using the anti-MKP-1 antibody. rMKP-1 or vector-transfected
VSMCs were serum-starved for 3 days and treated with mechanical stress
for the indicated times (60 cycles/min, 15% elongation). Western blot
analysis was performed for the phosphorylated (P) ERK1/2
(panel B), JNK1/2 (panel C), and p38 MAPK
(panel D). Panel E, VSMC proliferation assays.
VSMC cell lines were serum-starved for 4 days and treated with
mechanical stress for 30 min and incubated at 37 °C for 24 h.
[3H]Thymidine was added for 4 h before harvest.
Radiation activities were measured. Data are means ± S.D. of
triplicates from two independent experiments. *, significant difference
from vector-transfected cells. N, neo;
M, MPK-1.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
q
oligonucleotides inhibited shear stress-induced Ras-GTPase activity,
whereas scrambled oligonucleotide treatment had no effect. Treatment of
endothelial cells with pertussis toxin prevented shear stress-mediated
activation of ERK1/2 (35, 47). G proteins reconstituted in liposomes, in the absence of receptors, show an increase in activity in response to shear stress (35). This assumption is supported by our results (Figs. 5 and 6) that expression of dominant negative Ras and Rac in
VSMCs exposed to mechanical stress could significantly inhibit MKP-1
expression. These observations suggest that increases in the
elongational and transitional mobility in cell membranes activate membrane-bound G proteins by facilitating exchange of GDP to GTP, subsequently leading to MAPK activation and MKP-1 expression. Our
hypothesis is schematically depicted in Fig.
10.

View larger version (19K):
[in a new window]
Fig. 10.
Schematic representation of growth factor
receptor-dependent and -independent activation of G
proteins by mechanical stress. Increase in the elongational and
translational mobility in membrane results in exposure of kinase
domains of growth factor receptors and/or conformation of
membrane-bound G proteins, which lead to receptor autophosphorylation
or facilitating exchange of GDP for GTP. Subsequently, activation of
MAPKs mediates MKP-1 expression, which serves as a negative regulator
for MAPKs. MEK, MAPK/ERK kinase.
In our study system, we demonstrated that MAPKs play an important role in mediating mechanical stress-induced MKP-1 expression, because both PD 98059 (MEK inhibitor) and SB 202190 (p38 MAPK inhibitor) could inhibit MKP-1 expression. The time course of phosphorylation of three MAPKs appears simultaneously. Therefore, mechanical stress-induced MKP-1 expression is dependent on ERK, p38 MAPK, and possibly JNK/SAPK activation. On the other hand, MKP-1 as a negative regulator for dephosphorylation and inactivation of MAPKs has been implicated in other types of cells (9-12, 17, 18). Herein, we provided direct evidence that MKP-1 dephosphorylated three members of MAPKs in stressed VSMCs. Overexpression of MKP-1 could significantly inhibit phosphorylation and activation of MAPKs and DNA synthesis (Fig. 9), indicating important roles of MKP-1 in regulating MAPK activation and cell proliferation.
All tissues in the body are subjected to physical forces originating
either from tension, created by cells themselves, or from the
environment (8, 35, 62-64). The role of mechanical force as an
important regulator of structure and function of mammalian cells,
tissues, and organs has recently been recognized. Physical stimuli must
be sensed by cells and transmitted through intracellular signal
transduction pathways to the nucleus, resulting in physiological responses or pathological conditions. Growth and proliferation of VSMCs
have been shown to be associated with numerous vascular disease states,
including medial hypertrophy in hypertension, intimal thickening in
atherosclerosis, and restenosis after angioplasty, and are believed to
be related with a sustained mechanical stress (21, 27, 35). Thus, we
postulate that the balance between MKP-1 and MAPK levels induced by
mechanical stress in VSMCs is critical to maintain homeostasis of the
arterial wall. From a therapeutic point of view, our understanding of
the molecular mechanisms regulating MAPK and MAPK phosphatase
activities by mechanical stress could lead to new strategies for the
effective prevention and control of vascular disorders.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. G. Wick for this continuous support. We thank Drs. N. J. Holbrook and Y. Liu (National Institute on Aging, Baltimore, MD) for providing MKP-1 plasmid, Dr. J. Woodgett (Ontario Cancer Institute, Toronto, Canada) for providing the GST-c-Jun expression vector, Dr. G. Baier (Institute for Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria) for kindly providing the dominant negative Ras N17, Rac1 N17 plasmids, and antibody against myc-tag, G. Sturm for excellent technical assistance, and T Öttl for the preparation of photographs.
| |
FOOTNOTES |
|---|
* This work was supported by Austrian Science Fund Grants P12568-MED and P13099-MED (to Q. X.) and Austrian National Bank Jubiläumsfonds Grant P6286 (to Q. X.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute for
Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, A-6020 Innsbruck, Austria. Tel.: 43 512 583 9190; Fax: 43 512 583 9198;
E-mail: qingbo.xu@oeaw.ac.at.
2 B. Metzler, Y. Hu, H. Dietrich, and Q. Xu, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MAPK(s), mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; GST, glutathione S-transferase; JNK, c-Jun NH2-terminal protein kinase; MKP, MAPK phosphatase; rMKP, rat MKP; SAPK, stress-activated protein kinase; VSMC, vascular smooth muscle cell; Mops, 4-morpholinepropanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Davis, R. J.
(1993)
J. Biol. Chem.
268,
14553-14556 |
| 2. | Seger, R., and Krebs, E. G. (1995) FASEB J. 9, 726-735[Abstract] |
| 3. | Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994) Nature 369, 156-160[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Hu, Y.,
Cheng, L.,
Hochleitner, B. W.,
and Xu, Q.
(1997)
Arterioscler. Thromb. Vasc. Biol.
17,
2808-2816 |
| 5. |
Pyles, J. M.,
March, K. L.,
Franklin, M.,
Mehdi, K.,
Wilensky, R. L.,
and Adam, L. P.
(1997)
Circ. Res.
81,
904-910 |
| 6. | Lille, S., Daum, G., Clowes, M. M., and Clowes, A. W. (1997) J. Surg. Res. 70, 178-186[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Koyama, H.,
Olson, N. E.,
Dastvan, F. F.,
and Reidy, M. A.
(1998)
Circ. Res.
82,
713-721 |
| 8. | Xu, Q., Liu, Y., Gorospe, M., Udelsman, R., and Holbrook, N. J. (1996) J. Clin. Invest. 97, 508-514[Medline] [Order article via Infotrieve] |
| 9. |
Sun, H.,
Tonks, N. K.,
and Bar-Sagi, D.
(1994)
Science
266,
285-288 |
| 10. |
Misra-Press, A.,
Rim, C. S.,
Yao, H.,
Roberson, M. S.,
and Stork, P. J.
(1995)
J. Biol. Chem.
270,
14587-14596 |
| 11. |
Liu, Y.,
Gorospe, M.,
Yang, C.,
and Holbrook, N. J.
(1995)
J. Biol. Chem.
270,
8377-8380 |
| 12. | Lai, K., Wang, H., Lee, W. S., Jain, M. K., Lee, M. E., and Haber, E. (1996) J. Clin. Invest. 98, 1560-1567[Medline] [Order article via Infotrieve] |
| 13. |
Duff, J. L.,
Marrero, M. B.,
Paxton, W. G.,
Charles, C. H.,
Lau, L. F.,
Bernstein, K. E.,
and Berk, B. C.
(1993)
J. Biol. Chem.
268,
26037-26040 |
| 14. |
Guyton, K. Z.,
Liu, Y.,
Gorospe, M.,
Xu, Q.,
and Holbrook, N. J.
(1996)
J. Biol. Chem.
271,
4138-4142 |
| 15. |
Metzler, B.,
Hu, Y.,
Sturm, G.,
Wick, G.,
and Xu, Q.
(1998)
J. Biol. Chem.
273,
33320-33326 |
| 16. |
Bokemeyer, D.,
Lindemann, M.,
and Kramer, H. J.
(1998)
Hypertension
32,
661-667 |
| 17. |
Begum, N.,
Ragolia, L.,
Rienzie, J.,
McCarthy, M.,
and Duddy, N.
(1998)
J. Biol. Chem.
273,
25164-25170 |
| 18. |
Begum, N.,
Song, Y.,
Rienzie, J.,
and Ragolia, L.
(1998)
Am. J. Physiol.
275,
C42-C49 |
| 19. |
Davies, P. F.
(1995)
Physiol. Rev.
75,
519-560 |
| 20. | Patrick, C. W., Jr., and McIntire, L. V. (1995) Blood Purif. 13, 112-124[Medline] [Order article via Infotrieve] |
| 21. | Vinters, H. V., and Berliner, J. A. (1987) Diabetes Metab. 13, 294-300 |
| 22. | Henry, J. P., and Grim, C. E. (1990) J. Hypertens. 8, 783-793[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Pickering, T. G. (1988) in Behavioural Medicine in Cardiovascular Disorders (Elbert, T. , and Vaitl, D., eds) , pp. 27-85, John Wiley & Sons, Inc., New York |
| 24. | Folkow, B. (1995) Hypertension 13, 1546-1559 |
| 25. | Dzau, V. J., Gibbons, G. H., Morishita, R., and Pratt, R. E. (1994) Hypertension 23, 1132-1140[Abstract] |
| 26. | DeBakey, M. E., Lawrie, G. M., and Glaeser, D. H. (1985) Ann. Surg. 201, 115-131[Medline] [Order article via Infotrieve] |
| 27. |
Thubrikar, M. J.,
and Robicsek, F.
(1995)
Ann. Thorac. Surg.
59,
1594-1603 |
| 28. |
Rubanyi, G. M.,
Romero, J. C.,
and Vanhoutte, P. M.
(1986)
Am. J. Physiol.
250,
H1145-H1149 |
| 29. | Bhagyalakshmi, A., and Frangos, J. A. (1989) Biochem. Biophys. Res. Commun. 158, 31-37[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Kuchan, M. J.,
and Frangos, J. A.
(1993)
Am. J. Physiol.
264,
H150-H156 |
| 31. |
Wilson, E.,
Mai, Q.,
Sudhir, K.,
Weiss, R. H.,
and Ives, H. E.
(1993)
J. Cell Biol.
123,
741-747 |
| 32. |
Cheng, G. C.,
Briggs, W. H.,
Gerson, D. S.,
Libby, P.,
Grodzinsky, A. J.,
Gray, M. L.,
and Lee, R. T.
(1997)
Circ. Res.
80,
28-36 |
| 33. |
Yamazaki, T.,
Komuro, I.,
Kudoh, S.,
Zou, Y.,
Shiojima, I.,
Mizuno, T.,
Takano, H.,
Hiroi, Y.,
Ueki, K.,
Tobe, K.,
Kadowaki, T.,
Nagai, R.,
and Yazaki, Y.
(1995)
Circ. Res.
77,
258-265 |
| 34. |
Kudoh, S.,
Komuro, I.,
Hiroi, Y.,
Zou, Y.,
Harada, K.,
Sugaya, T.,
Takekoshi, N.,
Murakami, K.,
Kadowaki, T.,
and Yazaki, Y.
(1998)
J. Biol. Chem
273,
24037-24043 |
| 35. |
Traub, O.,
and Berk, B. C.
(1998)
Arterioscler. Thromb. Vasc. Biol.
18,
677-685 |
| 36. |
Xu, Q.,
Fawcett, T. W.,
Gorospe, M.,
Guyton, K. Z.,
Liu, Y.,
and Holbrook, N. J.
(1997)
Hypertension
30,
106-111 |
| 37. | Ross, R., and Kariya, B. (1980) in Handbook of Physiology: Circulation, Vascular Smooth Muscle (Bohr, D. F. , Somlyo, A. P. , and Sparks, H. V., eds) , pp. 69-91, American Physiological Society, Bethesda, MD |
| 38. | Xu, Q., Li, D. G., Holbrook, N. J., and Udelsman, R. (1995) Circulation 92, 1223-1229[Medline] [Order article via Infotrieve] |
| 39. | Banes, A. J., Gilbert, J., Taylor, D., and Monbureau, O. (1985) J. Cell Sci. 75, 35-42[Abstract] |
| 40. |
Hu, Y.,
Bock, G.,
Wick, G.,
and Xu, Q.
(1998)
FASEB J.
12,
1135-1142 |
| 41. | Pomerantz, K. B., Lander, H. M., Summers, B., Robishaw, J. D., Balcueva, E., and Hajjar, D. P. (1997) Biochemistry 36, 9523-9531[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Xu, Q., Hu, Y., Kleindienst, R., and Wick, G. (1997) J. Clin. Invest. 100, 1089-1097[Medline] [Order article via Infotrieve] |
| 43. | Liu, Y., Guyton, K. Z., Gorospe, M., Xu, Q., Lee, J. C., and Holbrook, N. J. (1996) Free Radic. Biol. Med. 21, 771-781[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Hu, Y.,
Metzler, B.,
and Xu, Q.
(1997)
J. Biol. Chem.
272,
9113-9119 |
| 45. | Reusch, H. P., Chan, G., Ives, H. E., and Nemenoff, R. A. (1997) Biochem. Biophys. Res. Commun. 237, 239-244[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Hamada, K.,
Takuwa, N.,
Yokoyama, K.,
and Takuwa, Y.
(1998)
J. Biol. Chem.
273,
6334-6340 |
| 47. |
Gudi, S.,
Nolan, J. P.,
and Frangos, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2515-2519 |
| 48. | Pracyk, J. B., Tanaka, K., Hegland, D. D., Kim, K. S., Sethi, R., Rovira, I. I., Blazina, D. R., Lee, L., Bruder, J. T., Kovesdi, I., Goldshmidt-Clermont, P. J., Irani, K., and Finkel, T. (1998) J. Clin. Invest. 102, 929-937[Medline] [Order article via Infotrieve] |
| 49. |
Park, J. M.,
Borer, J. G.,
Freeman, M. R.,
and Peters, C. A.
(1998)
Am. J. Physiol.
275,
C1247-C1254 |
| 50. | Songu-Mize, E., Liu, X., and Hymel, L. J. (1998) Am. J. Med. Sci. 316, 196-199[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Li, Q., Muragaki, Y., Hatamura, I., Ueno, H., and Ooshima, A. (1998) J. Vasc. Res. 35, 93-103[CrossRef][Medline] [Order article via Infotrieve] |
| 52. |
Cowan, D. B.,
Lye, S. J.,
and Langille, B. L.
(1998)
Circ. Res.
82,
786-793 |
| 53. |
Ohya, Y.,
Adachi, N.,
Nakamura, Y.,
Setoguchi, M.,
Abe, I.,
and Fujishima, M.
(1998)
Hypertension
31,
254-258 |
| 54. |
Redmond, E. M.,
Cahill, P. A.,
and Sitzmann, J. V.
(1998)
Arterioscler. Thromb. Vasc. Biol.
18,
75-83 |
| 55. |
Okada, M.,
Matsumori, A.,
Ono, K.,
Furukawa, Y.,
Shioi, T.,
Iwasaki, A.,
Matsushima, K.,
and Sasayama, S.
(1998)
Arterioscler. Thromb. Vasc. Biol.
18,
894-901 |
| 56. | Cano, E., and Mahadevan, L. C. (1995) Trends Biochem. Sci. 20, 117-122[CrossRef][Medline] [Order article via Infotrieve] |
| 57. | Davis, R. J. (1995) Mol. Reprod. Dev. 42, 459-467[CrossRef][Medline] [Order article via Infotrieve] |
| 58. |
Cobb, M. H.,
and Goldsmith, E. J.
(1995)
J. Biol. Chem.
270,
14843-14846 |
| 59. | Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, JM., and Zon, L. I. (1994) Nature 372, 794-798[Medline] [Order article via Infotrieve] |
| 60. | Johnson, G. L., and Vaillancourt, R. R. (1994) Curr. Opin. Cell Biol. 6, 230-238[CrossRef][Medline] [Order article via Infotrieve] |
| 61. | Bokemeyer, D., Sorokin, A., and Dunn, M. J. (1996) Kidney Int. 49, 1187-1198[Medline] [Order article via Infotrieve] |
| 62. | Zou, Y., Hu, Y., Metzler, B., and Xu, Q. (1998) Int. J. Mol. Med. 1, 827-384 [Medline] [Order article via Infotrieve] |
| 63. | Yamazaki, T., Komuro, I., and Yazaki, Y. (1996) Mol. Cell. Biochem. 163-164, 197-201[CrossRef] |
| 64. | Banes, A. J., Link, G. W., Jr., Gilbert, J. W., Tran Son Tay, R., and Monbureau, O. (1990) Am. Biotechnol. Lab. 8, 12-22[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi The cell biology of bone metabolism J. Clin. Pathol., May 1, 2008; 61(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi Angiotensin II Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition Hypertension, May 1, 2008; 51(5): 1339 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Richard, J. F. Deniset, A. L. Kneesh, D. Blackwood, and G. N. Pierce Mechanical Stretching Stimulates Smooth Muscle Cell Growth, Nuclear Protein Import, and Nuclear Pore Expression through Mitogen-activated Protein Kinase Activation J. Biol. Chem., August 10, 2007; 282(32): 23081 - 23088. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Shi, Y.-J. Chiu, Y. Cho, T. A. Bullard, M. Sokabe, and K. Fujiwara Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch Cardiovasc Res, March 1, 2007; 73(4): 813 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otis and N. Gallo-Payet Differential Involvement of Cytoskeleton and Rho-Guanosine 5'-Triphosphatases in Growth-Promoting Effects of Angiotensin II in Rat Adrenal Glomerulosa Cells Endocrinology, November 1, 2006; 147(11): 5460 - 5469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Olson, K. N. Protheroe, J. L. Segar, and T. D. Scholz Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1587 - H1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mayr, Y. Zou, Z. Zhang, H. Dietrich, Y. Hu, and Q. Xu Accelerated Arteriosclerosis of Vein Grafts in Inducible NO Synthase-/- Mice Is Related to Decreased Endothelial Progenitor Cell Repair Circ. Res., February 17, 2006; 98(3): 412 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Harper, S. M. Alvares, and W. G. Carter Wounding activates p38 map kinase and activation transcription f |